share_log

HC Wainwright & Co. Maintains Buy on LAVA Therapeutics, Lowers Price Target to $6

HC Wainwright & Co. Maintains Buy on LAVA Therapeutics, Lowers Price Target to $6

HC Wainwright & Co.維持對LAVA Therapeutics的買入,將目標價下調至6美元
Benzinga ·  2023/08/23 06:17

HC Wainwright & Co. analyst Arthur He maintains LAVA Therapeutics (NASDAQ:LVTX) with a Buy and lowers the price target from $9 to $6.

HC Wainwright & Co. 分析師Arthur He將LAVA Therapeutics(納斯達克股票代碼:LVTX)維持買入,並將目標股價從9美元下調至6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論